A detailed history of D L Carlson Investment Group Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, D L Carlson Investment Group Inc holds 6,415 shares of LLY stock, worth $5.83 Million. This represents 1.15% of its overall portfolio holdings.

Number of Shares
6,415
Previous 6,460 0.7%
Holding current value
$5.83 Million
Previous $5.03 Million 15.58%
% of portfolio
1.15%
Previous 0.99%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$724.87 - $909.04 $32,619 - $40,906
-45 Reduced 0.7%
6,415 $5.81 Million
Q1 2024

May 14, 2024

SELL
$592.2 - $792.28 $94,752 - $126,764
-160 Reduced 2.42%
6,460 $5.03 Million
Q4 2023

Feb 16, 2024

BUY
$525.19 - $619.13 $3.22 Million - $3.79 Million
6,128 Added 1245.53%
6,620 $3.86 Million
Q3 2023

Nov 02, 2023

BUY
$434.7 - $599.3 $213,872 - $294,855
492 New
492 $264,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $864B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track D L Carlson Investment Group Inc Portfolio

Follow D L Carlson Investment Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D L Carlson Investment Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on D L Carlson Investment Group Inc with notifications on news.